These findings provide compelling evidence that NR2E3 ablation promotes liver tumor formation and progression by enhanced activation of the Wnt/β‐catenin signaling pathway concurrent with inactivation of the tumor suppressive p53 signaling pathway. This evidence concerns the gene NR2E3 and neoplasm.